Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 3;13(1):241.
doi: 10.1038/s41398-023-02545-9.

Autoantibodies in patients with obsessive-compulsive disorder: a systematic review

Affiliations

Autoantibodies in patients with obsessive-compulsive disorder: a systematic review

Dominik Denzel et al. Transl Psychiatry. .

Abstract

Obsessive-compulsive disorder (OCD) is a frequent and debilitating mental illness. Although efficacious treatment options are available, treatment resistance rates are high. Emerging evidence suggests that biological components, especially autoimmune processes, may be associated with some cases of OCD and treatment resistance. Therefore, this systematic literature review summarizing all case reports/case series as well as uncontrolled and controlled cross-sectional studies investigating autoantibodies in patients with OCD and obsessive-compulsive symptoms (OCS) was performed. The following search strategy was used to search PubMed: "(OCD OR obsessive-compulsive OR obsessive OR compulsive) AND (antib* OR autoantib* OR auto-antib* OR immunoglob* OR IgG OR IgM OR IgA)". Nine case reports with autoantibody-associated OCD/OCS were identified: five patients with anti-neuronal autoantibodies (against N-methyl-D-aspartate-receptor [NMDA-R], collapsin response mediator protein [CV2], paraneoplastic antigen Ma2 [Ma2], voltage gated potassium channel complex [VGKC], and "anti-brain" structures) and four with autoantibodies associated with systemic autoimmune diseases (two with Sjögren syndrome, one with neuropsychiatric lupus, and one with anti-phospholipid autoantibodies). Six patients (67%) benefited from immunotherapy. In addition, eleven cross-sectional studies (six with healthy controls, three with neurological/psychiatric patient controls, and two uncontrolled) were identified with inconsistent results, but in six studies an association between autoantibodies and OCD was suggested. In summary, the available case reports suggest an association between OCD and autoantibodies in rare cases, which has been supported by initial cross-sectional studies. However, scientific data is still very limited. Thus, further studies on autoantibodies investigated in patients with OCD compared with healthy controls are needed.

PubMed Disclaimer

Conflict of interest statement

DD: None. KR: None. BF: None. BP: None. KP: None. AS: None. KN: None. UV: None. LTvE: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics. KD: Steering Committee Neurosciences, Janssen. Speaker fees from Janssen. MAS: None. DE: None.

Figures

Fig. 1
Fig. 1. PRISMA flow diagram for systematic literature search.
*Screened reviews and meta-analyses: [–, –43]. Additional case study from references of case report [45]: [49]. Included controlled studies into systematic review: [, –61, 63]. Included uncontrolled studies into systematic review: [54, 62]. Included case reports into systematic review: [–50, 52]. Incl. Inclusion, Syst. Systematic, Rev. Review.

Similar articles

Cited by

References

    1. Adam Y, Meinlschmidt G, Gloster AT, Lieb R. Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment. Social Psychiatry Psychiatric Epidemiol. 2012;47:339–49. doi: 10.1007/s00127-010-0337-5. - DOI - PubMed
    1. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The Epidemiology of Obsessive-Compulsive Disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15:53–63. doi: 10.1038/mp.2008.94. - DOI - PMC - PubMed
    1. Anholt GE, Aderka IM, Van Balkom AJLM, Smit JH, Schruers K, Van Der Wee NJA, et al. Age of onset in obsessive-compulsive disorder: Admixture analysis with a large sample. Psychological Medicine. 2014;44:185–94. doi: 10.1017/S0033291713000470. - DOI - PubMed
    1. Glazier K, Calixte RM, Rothschild R, Pinto A. High rates of OCD symptom misidentification by mental health professionals. Ann Clin Psychiatry. 2013;25:201–9. - PubMed
    1. Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, et al. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectrums. 2003;8:7–16. doi: 10.1017/S1092852900006908. - DOI - PubMed

Publication types

Substances